Mackenzie Kinney
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mackenzie Kinney has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Kathryn Futrega
National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD 20892, USA
2 shared publications - Michael Robert Doran
School of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, Qld, Australia
2 shared publications - Ena Music
School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Brisbane, Australia
1 shared publication - James S. Palmer
School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Brisbane, Australia
1 shared publication - James S. Palmer
Institute of Health and Biomedical Innovation, Queensland University of Technology at The Translational Research Institute, Brisbane, QLD, Australia
1 shared publication - Mark Ungrin
Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada
1 shared publication
Latest Publications
- Open Access
- 29 July 2020
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 11 (1) , 1-10
Intermittent parathyroid hormone (1–34) supplementation of bone marrow stromal cell cultures may inhibit hypertrophy, but at the expense of chondrogenesis
Background: Bone marrow stromal cells (BMSC) have promise in cartilage tissue engineering, but for their potential to be fully realised, the propensity to undergo hypertrophy must be mitigated. The literature contains diverging reports on the effect of parathyroid hormone (PTH) on BMSC differentiation. Cartilage tissue models can be heterogeneous, confounding efforts to improve media formulations. Methods: Herein, we use a novel microwell platform (the Microwell-mesh) to manufacture hundreds of small-diameter homogeneous micro-pellets and use this high-resolution assay to quantify the influence of constant or intermittent PTH(1–34) medium supplementation on BMSC chondrogenesis and hypertrophy. Micro-pellets were manufactured from 5000 BMSC each and cultured in standard chondrogenic media supplemented with (1) no PTH, (2) intermittent PTH, or (3) constant PTH. Results: Relative to control chondrogenic cultures, BMSC micro-pellets exposed to intermittent PTH had reduced hypertrophic gene expression following 1 week of culture, but this was accompanied by a loss in chondrogenesis by the second week of culture. Constant PTH treatment was detrimental to chondrogenic culture. Conclusions: This study provides further clarity on the role of PTH on chondrogenic differentiation in vitro and suggests that while PTH may mitigate BMSC hypertrophy, it does so at the expense of chondrogenesis.
- 29 July 2020
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 11 (1) , 1-10
Open AccessIntermittent parathyroid hormone (1–34) supplementation of bone marrow stromal cell cultures may inhibit hypertrophy, but at the expense of chondrogenesis
Background: Bone marrow stromal cells (BMSC) have promise in cartilage tissue engineering, but for their potential to be fully realised, the propensity to undergo hypertrophy must be mitigated. The literature contains diverging reports on the effect of parathyroid hormone (PTH) on BMSC differentiation. Cartilage tissue models can be heterogeneous, confounding efforts to improve media formulations. Methods: Herein, we use a novel microwell platform (the Microwell-mesh) to manufacture hundreds of small-diameter homogeneous micro-pellets and use this high-resolution assay to quantify the influence of constant or intermittent PTH(1–34) medium supplementation on BMSC chondrogenesis and hypertrophy. Micro-pellets were manufactured from 5000 BMSC each and cultured in standard chondrogenic media supplemented with (1) no PTH, (2) intermittent PTH, or (3) constant PTH. Results: Relative to control chondrogenic cultures, BMSC micro-pellets exposed to intermittent PTH had reduced hypertrophic gene expression following 1 week of culture, but this was accompanied by a loss in chondrogenesis by the second week of culture. Constant PTH treatment was detrimental to chondrogenic culture. Conclusions: This study provides further clarity on the role of PTH on chondrogenic differentiation in vitro and suggests that while PTH may mitigate BMSC hypertrophy, it does so at the expense of chondrogenesis.
- Open Access
- 1 September 2015
- Published by Elsevier in Biomaterials
- Vol. 62, 1-12
The microwell-mesh: A novel device and protocol for the high throughput manufacturing of cartilage microtissues
- 1 September 2015
- Published by Elsevier in Biomaterials
- Vol. 62, 1-12
Open AccessThe microwell-mesh: A novel device and protocol for the high throughput manufacturing of cartilage microtissues